IPS admits medication shortages persist but says critical stock has decreased

The Paraguayan Social Security Institute (IPS) has acknowledged persistent medication shortages, even in critical areas like cardiology and oncology. Despite these ongoing challenges, the institute reports a significant reduction in its critical stock of medications, down from over 530 to fewer than 90.

Derlis León, the IPS Health Manager, admitted that the lack of essential drugs continues to affect various medical departments. He confirmed shortages in hypertension medications for cardiology and vital drugs for oncology, though he stated that therapeutic alternatives are available. León emphasized that the regularization of medication supply is a collaborative effort involving the Health, Logistics, and Financial Management departments, with ongoing discussions with the pharmaceutical industry.

León also highlighted the IPS's initiative to implement a "virtual hospital." This program aims to resolve up to 50% of patient problems through virtual consultations and remote follow-ups, initially targeting chronic patients over 55. The goal is to improve access to consultations and streamline medication protocol renewals, thereby mitigating some of the difficulties patients face in obtaining care.

Despite the acknowledged difficulties, León assured that the IPS is working tirelessly to resolve the situation, stating that asking for patience would be an insult. He stressed that the institution is committed to regularizing the supply of medications and improving patient services through both traditional and virtual means.